Business
Hims & Hers Shares Double on Report of Wegovy Tie-Up
Shares in telehealth company Hims & Hers skyrocketed in premarket trading following a media report that the maker of Wegovy plans to sell the weight-loss drug on the platform, a move that would end a legal spat between the two companies.
Hims & Hers, which markets consumer drugs ranging from treatments for weight loss and erectile dysfunction in men, to treatments for menopausal symptoms in women, is set to offer Novo Nordisk’s NOVO.B 0.99%increase; green up pointing triangle blockbuster Wegovy on its platform, Bloomberg reported, citing an unnamed source.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8